Orthofix Medical Inc. (OFIX)Healthcare | Medical Devices | Lewisville, United States | NasdaqGS
11.79 USD
+0.16
(1.376%)
⇧
(July 13, 2026, 4 p.m.
EDT)
After hours: 11.79 |
Hot Take ↕ | July 11, 2026, 5:23 a.m. EDT
The immediate outlook is clouded by a severe multi-year structural decline. Despite a recent bounce back to $11.63, the stock has lost over 76% of its value over the last nine years, with four consecutive years of negative annual returns ending last year. This persistent downward trajectory suggests the market views the current business fundamentals as deeply impaired, regardless of the recent positive news regarding Medicare reimbursement. The balance sheet is fragile, carrying debt that exceeds cash reserves, while profitability remains elusive with negative operating margins and a trailing PEG ratio of nearly 49, signaling extreme inefficiency in valuation relative to growth. While the forward P/E looks attractive at 13.8x, it is based on estimated earnings of $0.84, which is speculative given the company's history of losses. The options market confirms this skepticism, with traders buying protection at lower levels rather than betting on a breakout. Until the company demonstrates sustained profitability and reverses the multi-year price trend, the risk-reward profile remains skewed heavily against the investor. |
| Model | MAE |
|---|---|
| AutoARIMA ✓ | 0.181410 |
| AutoTheta | 0.181822 |
| AutoETS | 0.183915 |
| MSTL | 0.186714 |
Forecast horizon: 45 days | Selected: AutoARIMA
| Forecast Reliability | |
|---|---|
| Score | 38% |
| H-stat | 3.87 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.061 |
| Excess Kurtosis | -1.55 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 60.263 |
| Revenue per Share | 20.677 |
| Market Cap | 476,571,264 |
| Forward P/E | 14.04 |
| Beta | 0.71 |
| Profit Margins | -7.27% |
| Website | https://orthofix.com |
As of July 11, 2026, 5:23 a.m. EDT: Speculators are positioning defensively with heavy out-of-the-money put volume at strikes significantly below current price ($7.50, $10.00), creating a 'floor' scenario. Conversely, call activity is sparse and concentrated near the money, indicating a lack of aggressive bullish conviction despite the recent price recovery. Implied volatility remains elevated on near-term expirations, suggesting fear of further downside rather than anticipation of a major rally.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.0591985 |
| Address1 | 3,451 Plano Parkway |
| All Time High | 74.44 |
| All Time Low | 5.625 |
| Ask | 15.04 |
| Ask Size | 2 |
| Audit Risk | 2 |
| Average Analyst Rating | 2.0 - Buy |
| Average Daily Volume10 Day | 526,840 |
| Average Daily Volume3 Month | 414,386 |
| Average Volume | 414,386 |
| Average Volume10Days | 526,840 |
| Beta | 0.712 |
| Bid | 8.58 |
| Bid Size | 2 |
| Board Risk | 2 |
| Book Value | 10.777 |
| City | Lewisville |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 8 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 11.79 |
| Current Ratio | 2.866 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 12.04 |
| Day Low | 11.58 |
| Debt To Equity | 60.263 |
| Display Name | Orthofix Medical |
| Earnings Call Timestamp End | 1,777,984,200 |
| Earnings Call Timestamp Start | 1,777,984,200 |
| Earnings Timestamp | 1,777,984,200 |
| Earnings Timestamp End | 1,785,846,600 |
| Earnings Timestamp Start | 1,785,846,600 |
| Ebitda | 17,004,000 |
| Ebitda Margins | 0.020599999 |
| Enterprise To Ebitda | 36.377 |
| Enterprise To Revenue | 0.749 |
| Enterprise Value | 618,548,288 |
| Eps Current Year | 0.3 |
| Eps Forward | 0.84 |
| Eps Trailing Twelve Months | -1.5 |
| Esg Populated | 0 |
| Exchange | NMS |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 10.5654 |
| Fifty Day Average Change | 1.2245998 |
| Fifty Day Average Change Percent | 0.11590662 |
| Fifty Two Week Change Percent | 5.91985 |
| Fifty Two Week High | 16.99 |
| Fifty Two Week High Change | -5.2 |
| Fifty Two Week High Change Percent | -0.30606237 |
| Fifty Two Week Low | 8.85 |
| Fifty Two Week Low Change | 2.9399996 |
| Fifty Two Week Low Change Percent | 0.33220333 |
| Fifty Two Week Range | 8.85 - 16.99 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 704,122,200,000 |
| Float Shares | 40,102,725 |
| Forward Eps | 0.84 |
| Forward P E | 14.035715 |
| Free Cashflow | 22,024,250 |
| Full Exchange Name | NasdaqGS |
| Full Time Employees | 1,605 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.71011 |
| Gross Profits | 586,102,976 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.02194 |
| Held Percent Institutions | 0.91874003 |
| Implied Shares Outstanding | 40,421,652 |
| Industry | Medical Devices |
| Industry Disp | Medical Devices |
| Industry Key | medical-devices |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Long Business Summary | Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas. |
| Long Name | Orthofix Medical Inc. |
| Market | us_market |
| Market Cap | 476,571,264 |
| Market State | POSTPOST |
| Max Age | 86,400 |
| Message Board Id | finmb_32538 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -60,006,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 470,103,812 |
| Number Of Analyst Opinions | 4 |
| Open | 11.58 |
| Operating Cashflow | 34,128,000 |
| Operating Margins | -0.067540005 |
| Overall Risk | 3 |
| Payout Ratio | 0.0 |
| Peg Ratio | 48.83 |
| Phone | 214 937 2000 |
| Post Market Change | 0.0 |
| Post Market Change Percent | 0.0 |
| Post Market Price | 11.79 |
| Post Market Time | 1,783,981,118 |
| Previous Close | 11.63 |
| Price Eps Current Year | 39.3 |
| Price Hint | 2 |
| Price To Book | 1.0939964 |
| Price To Sales Trailing12 Months | 0.5774004 |
| Profit Margins | -0.0727 |
| Quick Ratio | 1.602 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | buy |
| Recommendation Mean | 2.0 |
| Region | US |
| Regular Market Change | 0.16 |
| Regular Market Change Percent | 1.37575 |
| Regular Market Day High | 12.04 |
| Regular Market Day Low | 11.58 |
| Regular Market Day Range | 11.58 - 12.04 |
| Regular Market Open | 11.58 |
| Regular Market Previous Close | 11.63 |
| Regular Market Price | 11.79 |
| Regular Market Time | 1,783,972,800 |
| Regular Market Volume | 264,623 |
| Return On Assets | -0.03254 |
| Return On Equity | -0.13432 |
| Revenue Growth | 0.016 |
| Revenue Per Share | 20.677 |
| Sand P52 Week Change | 0.20847368 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 1 |
| Shares Outstanding | 40,421,652 |
| Shares Percent Shares Out | 0.0585 |
| Shares Short | 2,363,876 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 1,950,321 |
| Short Name | Orthofix Medical Inc. |
| Short Percent Of Float | 0.0661 |
| Short Ratio | 5.44 |
| Source Interval | 15 |
| State | TX |
| Symbol | OFIX |
| Target High Price | 18.0 |
| Target Low Price | 12.0 |
| Target Mean Price | 15.5 |
| Target Median Price | 16.0 |
| Total Cash | 120,278,000 |
| Total Cash Per Share | 2.976 |
| Total Debt | 262,255,008 |
| Total Revenue | 825,374,016 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -1.5 |
| Trailing Peg Ratio | 48.825 |
| Triggerable | 1 |
| Two Hundred Day Average | 13.1523 |
| Two Hundred Day Average Change | -1.3622999 |
| Two Hundred Day Average Change Percent | -0.103578836 |
| Type Disp | Equity |
| Volume | 264,623 |
| Website | https://orthofix.com |
| Zip | 75,056 |